Drug Facts Label Review

U.S. OTC Drug Facts Label Layout & Claims Guidelines

Updated: Jun 2025QTC Global Compliance TeamRegulatory reference content

Interpreting US 21 CFR Part 201 labeling laws, detailing mandatory Drug Facts formatting, font criteria, active/inactive lists, and claim controls.

Key answer

U.S. OTC labels must include the standardized "Drug Facts" panel (21 CFR 201.66). The panel must detail: Active ingredients (with dosage strength), Uses (indications), Warnings, Directions, Other information, and Inactive ingredients. Any indications exceeding the OTC monograph or unapproved therapeutic claims (e.g., claiming to cure eczema) will classify the product as an "unapproved new drug," leading to detentions or enforcement.

Statutory Layout Specifications for Drug Facts

FDA labeling laws apply micro-level requirements on layout. Poorly formatted labels will be flagged as "misbranded drugs" during custom checks or consumer lawsuits.

  • Font sizes: standard text must be at least 6pt; heading titles must be at least 8pt
  • Box border: the entire Drug Facts panel must be isolated by solid lines from marketing text
  • Ingredient sequence: Inactive ingredients must be listed in alphabetical order, a very common mistake

FAQ

What is an OTC Monograph?+

An OTC Monograph is an FDA recipe and claim playbook for specific categories (e.g., sunscreens, acne treatments, analgesics). If your product formulation, strength, indications, and warnings match the monograph, it can be listed and sold without a NDA. Modifying monograph text risks misbranding.

Next steps

If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.